Hematological malignancies immunotherapy-related coagulopathy and laboratory tests
Yingying LI; Heng MEI; Yu HU.
Chinese Journal of Laboratory Medicine
; (12): 1000-1004, 2022.
ArtÃculo en Zh | WPRIM | ID: wpr-958615
Documentos relacionados
[Development of CAR-T Cells Effective against Solid Tumors].
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses.
Resistance and recurrence of malignancies after CAR-T cell therapy.
Resistance Mechanisms to Anti-PD Cancer Immunotherapy.
Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control.
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
Targeting RNA N<sup>6</sup>-methyladenosine modification: a precise weapon in overcoming tumor immune escape.
Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection.
Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China.
Targeted glycan degradation potentiates cellular immunotherapy for solid tumors.